Improved work productivity and enhanced health and wellbeing through novel lighting systems
Submitting Institution
University of SurreyUnit of Assessment
Allied Health Professions, Dentistry, Nursing and PharmacySummary Impact Type
HealthResearch Subject Area(s)
Medical and Health Sciences: Neurosciences
Psychology and Cognitive Sciences: Psychology
Summary of the impact
Circadian rhythms impact upon a large proportion of human biology.
Disruption due to genetic or environmental (e.g. altered sleep patterns in
shift workers) cues results in reduced quality of life and increased
morbidity for millions of people every year.
Researchers at Surrey first demonstrated blue light sensitivity of the
human circadian system, resulting in increased alertness and mood. This
led to changes in international lighting standards and the development and
use of novel lighting systems, such as blue-enriched polychromatic
lighting. These systems have been employed in homes for older people,
factories, offices, hospitals and schools, increasing health and
wellbeing.
Underpinning research
Light is the major time cue for the synchronisation and entrainment of
the human circadian timing system with the 24-h environmental light-dark
cycle. Research at the University of Surrey led by the teams of Arendt
(Professor of Endocrinology; now Emeritus), Dijk (Professor of Sleep and
Physiology) and Skene (Professor of Neuroendocrinology) has established
the importance of ocular light in the circadian system.
A pivotal study in blind people co-funded by the South Thames Regional
Health Authority and Servier, determined the importance of the ocular
light signal for circadian entrainment (1). The research
demonstrated that this ocular cue was vital to ensure good sleep at night,
reduced daytime napping and optimum performance and alertness during the
day (2). In 2001, a second pivotal study funded through EU-FP5
determined the spectral sensitivity of human circadian photoreception by
assessing the effect of a range of monochromatic light pulses at varying
intensities on light-induced suppression of nocturnal melatonin production
(3). The resulting action spectrum demonstrated for the first time
that short wavelength blue light (440 - 480 nm) was the most effective
light wavelength for light-induced melatonin suppression. In addition to
proving that these human light responses were not primarily mediated by
the classical rod and cone retinal photoreceptors, the results had
important implications for the field of lighting and health.
Based on these findings, a joint clinical study co-operation agreement
was initiated between Philips Lighting and the University of Surrey
(September 2004) to identify potential areas for commercial development,
which has led to several joint patents (EP1614441A1, published 11.01.2006;
EP 1317302B1 published 7.06.2006; EP 2286862 published 23.09.10 and also
granted in Australia, Taiwan and China).
In a series of publications, the initial observation that blue light is
most effective in controlling the biological clock was extended with
Surrey researchers demonstrating that blue-light intervention could
phase-advance clock timing, increase alertness, improve mood and affect
emotional brain responses. In 2005, it was demonstrated for the first time
that older people have reduced melatonin suppression (4) and
reduced alertness (5) in response to short wavelength blue light.
These findings have important implications for the design of lighting for
living environments of older people. In collaboration with Philips
Lighting and a 5 year New Dynamics of Ageing (NDA) Cross Council Research
Programme, blue-enriched polychromatic lighting has been investigated in
older people living in the community and in care homes.
Importantly, in addition to the observed benefits of blue-enriched
polychromatic lighting for the elderly, research at the University of
Surrey demonstrated that these benefits could be expanded to the
workplace, improving self-reported alertness, performance and sleep
quality (6).
References to the research
1. Lockley, S.W., Skene, D.J., Arendt, J.,Tabandeh, H., Bird, A.C.,
Defrance, R. Relationship between melatonin rhythms and visual loss in
the blind. Journal of Clinical Endocrinology and Metabolism. (1998)
82: 3763-3770. DOI: 10.1177/074873049701200104
2. Lockley, S.W., Dijk, D.J., Kosti, O., Skene, D.J. and Arendt, J. Alertness,
mood and performance rhythm disturbances associated with circadian sleep
disorders in the blind. Journal of Sleep Research. (2008) 17:
207-216. DOI: 10.1111/j.1365-2869.2008.00656.x
3. Thapan, K., Arendt, J. and Skene, D.J. An action spectrum for
melatonin suppression: evidence for a novel non-rod, non-cone
photoreceptor system in humans. Journal of Physiology (2001) 535:
261-267. DOI: 10.1111/j.1469-7793.2001.t01-1-00261.x
4. Herljevic, M., Middleton, B., Thapan, K. and Skene, D.J. Light-induced
melatonin suppression: Age-related reduction in response to short
wavelength light. Experimental Gerontology (2005) 40:
237-242. DOI: 10.1016/j.exger.2004.12.001
5. Sletten, T.L., Revell, V.L., Middleton, B., Lederle, K.A. and Skene,
D.J. Age-related changes in acute and phase advancing responses to
monochromatic light. Journal of Biological Rhythms (2009) 24:
73-84. DOI: 10.1177/0748730408328973
6. Viola A.U., James L.M., Schlangen L.J., Dijk D.J. Blue-enriched
white light in the workplace improves self-reported alertness,
performance and sleep quality. Scandinavian Journal of Work
Environment and Health (2008) 34:297-306. DOI: 10.5271/sjweh.1268
Details of the impact
The research conducted at Surrey has direct implications for lighting,
its design and implementation, in the home and workplace and has led to a
number of International Policy, Health & Wellbeing and Commercial
impacts.
On the basis of work carried out by the research team on the impact of
blue light on human action spectra, plus the related discovery by others
of the novel photopigment melanopsin, and the intrinsically photosensitive
retinal ganglion cells that drive these responses, a major policy
impact on lighting standards has been achieved. International
lighting standard organisations, e.g. DIN (Deutsches Institut für
Normung); CIE (International Commission on Illumination), set up specific
Task Forces to address this issue, with task force recommendations being
incorporated into current guidelines from 2009 onwards (Ref 1 and 2).
This policy impact has paved the way for the development of blue-enriched
lighting, providing a rationale for its use in personal, commercial and
healthcare settings. One of the joint patents between the University of
Surrey and Phillips Electronic N.V, complimented with novel clinical
studies was used to develop a new range of lighting products;
blue-enriched polychromatic lighting.
These products were initially developed as specialised light boxes,
providing timed, blue-enriched polychromatic lighting for individuals at
work or home (Ref 3). In addition to personal light boxes, the
reach of this impact was further extended through the development of
blue-enriched polychromatic traditional light fixtures. These lights are
suitable for use in the workplace, hospitals, schools and care homes,
where they positively impact on health and wellbeing, and productivity.
These lighting systems are proving to be of significant benefit in the
workplace, for example in factories of shift workers (Ref 4); in
care homes for the elderly (Ref 5); and in schools (SchoolVision®
system; Ref 6). The impact of the SchoolVision® system of
blue-enriched polychromatic lighting has been clearly proven in the
classroom, where reading speed increased by 35%, frequency of errors fell
by almost 45% and restfulness was reduced by 75% (Ref 7).
In summary, the identification of the health and wellbeing benefits of
blue-enriched polychromatic lighting by researchers at Surrey has had a
widespread impact. While the development of personal light boxes impacted
the health and wellbeing of many at an individual level, the expansion of
blue-enriched polychromatic lighting to traditional light fixtures extends
this impact to a larger population with its incorporation in the
workplace, schools and healthcare institutions. Equally, a significant,
and on-going, commercial impact has been achieved through the sales of
blue-enriched polychromatic lighting.
Sources to corroborate the impact
Ref 1. DIN Deutsches Institut für Normung E.V. - DIN V 5031-100:
Optical radiation physics and illuminating engineering - Part 100:
Non-visual effects of ocular light on human beings - Quantities, symbols
and action spectra (2009).
http://www.fnl.din.de/cmd?level=tpl-art-detailansicht&artid=118398668&committeeid=54738975&bcrumblevel=4&languageid=en
Ref 2. International Commission on Illumination (CIE) -
Proceedings of CIE symposium on Light and Health (2010)
http://www.cie.co.at/index.php/index.php?i_ca_id=719
Ref 3. Blue light-enriched lamps
http://download.p4c.philips.com/files/h/hf3227_60/hf3227_60_dfu_eng.pdf
http://download.p4c.philips.com/files/h/hf3310_60/hf3310_60_pss_aen.pdf
http://circadianbluelight.com/
http://lighting.com/blue-light-key-to-circadian/
Ref 4. Productivity Impact of blue-enriched polychromatic lighting
in the Workplace Quality System Manager / TPM Manager, ArcelorMittal
(Contact details provided)
Ref 5. Health and Wellbeing Impact of blue-enriched polychromatic
lighting in care homes Principal Scientist - Light, Health &
Well-being,
Brain, Body and Behaviour - Philips Group innovation, Research (Contact
details provided)
Ref 6. Health and Wellbeing Impact of blue-enriched polychromatic
lighting in schools Case study: Wintelre School, Wintelre, The Netherlands
http://www.lighting.philips.com/pwc_li/nl_nl/application_areas/pdf/CaseStudy_Wintelre.pdf
http://nos.nl/video/191170-van-blauw-licht-krijg-je-meer-energie.html
Ref 7. Knowledge Transfer Network: Energy Efficient Lighting in
the UK - a showcase guide https://connect.innovateuk.org/web/espktn